Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Victoria F. Balagon"'
Autor:
Chie Nakajima, Paul Saunderson, Kyaw Kyaw, Ma. Victoria F. Balagon, Yasuhiko Suzuki, Masanao Makino, Khin Saw Aye, Masanori Matsuoka, Robert H. Gelber, Esterlina V. Tan
Publikováno v:
Journal of Medical Microbiology. 57:1213-1219
A simple method to detect mutations in the genome of Mycobacterium leprae that confer resistance to key drugs for leprosy was exploited on the basis of a reverse hybridization system. A series of oligonucleotide probes corresponding to each mutation
Autor:
Vijaykumar Pannikar, Paul Saunderson, Eduardo C. Dela Cruz, R. H. Gelber, Kyaw Kyaw, Teky Budiawan, Esterlina V. Tan, Victoria F. Balagon, Masanori Matsuoka, Khin Saw Aye
Publikováno v:
Leprosy Review. 78:343-352
Introduction The magnitude of drug resistance in Mycobacterium leprae to dapsone, rifampicin, and ofloxacin was studied in three Southeast Asian countries with a high prevalence of leprosy. Methods M. leprae from the skin of leprosy patients was coll
Autor:
Eduardo C. Dela Cruz, R. V. Cellona, Rodolfo M. Abalos, Ma. Victoria F. Balagon, L. G. Villahermosa, Robert H. Gelber, Tranquilino T. Fajardo
Publikováno v:
Leprosy Review. 75:389-397
A 2-month clinical trial of pefloxacin and ofloxacin in previously untreated multibacillary patients was conducted at the Leonard Wood Memorial Leprosy Research Center, Cebu, the Philippines. Treatment with either pefloxacin or ofloxacin resulted in
Publikováno v:
The American journal of tropical medicine and hygiene. 83(3)
We evaluated the incidence, severity, and duration of reactional states in 139 multibacillary (MB) leprosy patients in the first 2 years after the completion of the 1 year regimen of multidrug therapy (MDT) currently recommended by the World Health O
Autor:
Robert H. Gelber, Greg C. Ireton, Mariane Martins de Araújo Stefani, Wakako Goto, Celina Maria Turchi Martelli, Masahiko Makino, Maria Nakatani, Steven G. Reed, Robson Crusue de Jesus, Ma. Victoria F. Balagon, Malcolm S. Duthie, Ludimila Paula Vaz Cardoso, Yumi Maeda, Daniel F. Hoft, Stephen T. Reece, Esterlina V. Tan, Eduardo Martins Netto
Publikováno v:
Clinical and vaccine immunology : CVI. 14(11)
Leprosy is a chronic and debilitating human disease caused by infection with the Mycobacterium leprae bacillus. Despite the marked reduction in the number of registered worldwide leprosy cases as a result of the widespread use of multidrug therapy, t
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 72(4)
A group of multibacillary patients is clearly at high risk for relapse following 2-yr WHO-MDT. Relapse is largely confined to BL or LL patients with a high BI initially, and occurs long after the discontinuation of therapy. This important group of pa
Autor:
Tranquilino T, Fajardo, Laarni G, Villahermosa, Eduardo C Dela, Cruz, Roland V, Cellona, Ma Victoria F, Balagon, Rodolfo M, Abalos, Robert H, Gelber
Publikováno v:
Leprosy review. 75(4)
A 2-month clinical trial of pefloxacin and ofloxacin in previously untreated multibacillary patients was conducted at the Leonard Wood Memorial Leprosy Research Center, Cebu, the Philippines. Treatment with either pefloxacin or ofloxacin resulted in
Autor:
R. M. Abalos, J. D. Watson, R. Prestidge, R. V. Cellona, Ma. Victoria F. Balagon, E. V. Tan, P. L. Tan, Douglas S. Walsh, G. P. Walsh
Publikováno v:
Clinical and experimental dermatology. 26(3)
The aim of new treatments for psoriasis is to induce extended remissions with fewer side-effects. Previous studies suggest that Mycobacterium vaccae, a harmless organism prepared as a heat-killed suspension, may induce periods of remission in some ps
Autor:
Joshua E. Lane, E. V. Tan, E. C. Dela Cruz, P. G. Sadaya, R. M. Abalos, G. P. Walsh, Ma. Victoria F. Balagon, Douglas S. Walsh, R. V. Cellona
Publikováno v:
Clinical and Experimental Dermatology. 31:469-470
Publikováno v:
International Journal of Leprosy and Other Mycobacterial Diseases. 72:493
A group of multibacillary patients is clearly at high risk for relapse following 2-yr WHO-MDT. Relapse is largely confined to BL or LL patients with a high BI initially, and occurs long after the discontinuation of therapy. This important group of pa